Golden Financial Statements From 2010 to 2024
| 4132 Stock | TWD 16.60 0.65 4.08% |
Check Golden Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Golden Biotechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Golden financial statements analysis is a perfect complement when working with Golden Biotechnology Valuation or Volatility modules.
Golden |
Golden Biotechnology Company Shares Outstanding Analysis
Golden Biotechnology's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Golden Biotechnology Shares Outstanding | 115.76 M |
Most of Golden Biotechnology's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Golden Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Golden Biotechnology has 115.76 M of shares currently outstending. This is 35.88% lower than that of the Healthcare sector and 71.18% lower than that of the Drug Manufacturers - Specialty & Generic industry. The shares outstanding for all Taiwan stocks is 79.76% higher than that of the company.
Golden Biotechnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Golden Biotechnology's current stock value. Our valuation model uses many indicators to compare Golden Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Golden Biotechnology competition to find correlations between indicators driving Golden Biotechnology's intrinsic value. More Info.Golden Biotechnology is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Golden Biotechnology's earnings, one of the primary drivers of an investment's value.About Golden Biotechnology Financial Statements
Golden Biotechnology investors use historical fundamental indicators, such as Golden Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Golden Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company. Golden Biotechnology Corporation was founded in 2002 and is based in New Taipei City, Taiwan. GOLDEN BIOTECHNOLOGY operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 135 people.
Pair Trading with Golden Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Golden Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Golden Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Golden Stock
| 0.75 | 1707 | Grape King Bio | PairCorr |
| 0.66 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.65 | 2357 | Asustek Computer | PairCorr |
| 0.63 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.6 | 2454 | MediaTek | PairCorr |
The ability to find closely correlated positions to Golden Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Golden Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Golden Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Golden Biotechnology to buy it.
The correlation of Golden Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Golden Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Golden Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Golden Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Golden Stock Analysis
When running Golden Biotechnology's price analysis, check to measure Golden Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Golden Biotechnology is operating at the current time. Most of Golden Biotechnology's value examination focuses on studying past and present price action to predict the probability of Golden Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Golden Biotechnology's price. Additionally, you may evaluate how the addition of Golden Biotechnology to your portfolios can decrease your overall portfolio volatility.